loader2
Login Open ICICI 3-in-1 Account
IPOLogoImag

SUDEEP PHARMA IPO

CLOSED

IPO Details

ICICI Direct Research Rating : UNRATED
21th Nov 2025
25th Nov 2025
25
₹ 14,075
₹ 563 - 593
₹ 895 Cr.

Issue timeline

  • 21-25 Nov 2025
  • 26-Nov-2025
  • 27-Nov-2025
  • 27-Nov-2025
  • 28-Nov-2025

Subscription Status

Shareholder -
Qualified Institutional Buyers -
Non-Institutional Investor -
Retail Individual Investor -
Employee -
Total -

About Company

Sudeep Pharma Limited is a pharmaceutical company operating within the highly regulated and essential pharmaceutical ingredients sector. The company was incorporated in 1989 and is headquartered in Gujarat, India, with its Manufacturing Facilities at Nandesari, Vadodara, and its Corporate Office at Gotri-Sevasi Road, Vadodara. The company is primarily engaged in the manufacturing of specialized Active Pharmaceutical Ingredients (APIs) and specialty ingredients for pharmaceutical, food, and nutrition industries. Sudeep Pharma serves both domestic and international pharmaceutical and nutraceutical markets.

Key Details of the IPO

The Initial Public Offering (IPO) by Sudeep Pharma Limited is structured as a 100% Book Built Offer, as per the Red Herring Prospectus (RHP) dated November 17, 2025. The Offer is a combination of a Fresh Issue of Equity Shares and an Offer for Sale (OFS) by the Promoter Selling Shareholders. The Fresh Issue comprises Equity Shares of face value ₹1, aggregating up to ₹95 Cr. The Offer for Sale involves up to 13,490,726 Equity Shares of face value ₹1 each. The total offer size is ₹895 Cr. The funds raised through the Fresh Issue are intended for funding capital expenditure for machinery procurement and general corporate purposes.

Business Model

Sudeep Pharma operates as a business-to-business (B2B) manufacturer and supplier of specialty chemicals and pharmaceutical ingredients. The model focuses on producing refined mineral-based APIs and excipients essential to the pharmaceutical, food, and nutrition industries. Their revenue is generated through long-term supply agreements with companies in these sectors. The model relies on stringent quality control and adherence to global regulatory certifications to serve a diversified global clientele.

Strengths & Risks

Strengths (4)

Serves 1,100+ global customers across pharmaceuticals, food, nutrition, and FMCG sectors.

Risks (4)

High regional concentration of manufacturing facilities in Vadodara.

Sudeep Pharma Ltd IPO FAQs

When does the Sudeep Pharma Ltd IPO open and close for subscription?

The Sudeep Pharma Ltd IPO will open for subscription on Friday, November 21, 2025, and will close on Tuesday, November 25, 2025

The price band for the Sudeep Pharma Ltd IPO is set at ₹563 to ₹593 per equity share with a face value of ₹1 each.

The minimum lot size for the Sudeep Pharma Ltd IPO is 25 shares. Consequently, the minimum investment required for a retail investor is ₹14,075 at the lower price band (₹563 per share) and ₹14,825 at the upper price band (₹593 per share).

The total issue size of the Sudeep Pharma Ltd IPO is up to 1,50,92,750 Equity Shares, consisting of both Fresh Issue and Offer for Sale. The aggregate monetary value is ₹895 Cr.

The book-running lead managers (BRLMs) for the Sudeep Pharma Ltd IPO are ICICI Securities Limited and IIFL Capital Services Limited

View More

*The financials mentioned above are sourced from DRHP/ RHP documents.